Cardiovascular Health with ENI's Whole Grape Extract
ENI
Breaking News on Supplements & Nutrition - North AmericaEU edition
All news > Videos
New science, dosage form drives vitamin K2 interest, NattoPharma CEO says
  |
Hogne Vik MD, PhDCEO - NattoPharmaNew research results are driving interest in vitamin K2, according to NattoPharma CEO Hogne Vik. But the company has also developed a new, more potent powder form that is helping to raise the ingredient's profile. Published: 17-May-2013 |
Trend-spotter: The rise of slow-energy
 |
David JagoDirector of innovation - MintelThere are two speeds when it comes to energy products: Slow and fast, says Mintel trend-spotting guru David Jago. Published: 17-May-2013 |
Global healthcare systems are failing; nutrition policy needs to change now, says leading academic
 |
Paul ClaytonProfessor - Oxford University Institute of Food Brain & BehaviourNations and populations are in peril of being swamped by the cost of their healthcare systems unless a severe nutrition policy rethink can occur, says a leading academic. Published: 16-May-2013 |
Delivering on the personalized nutrition promise
 |
Dilip Ghosh PhD, FACNDirector - NutriConnectPersonalized nutrition has been the Holy Grail of nutrition science. Dilip Ghosh, PhD, tells how the industry is getting closer to delivering on the promises that this approach implies. Published: 16-May-2013 |
Happy holidays from William Reed Business Media!
 |
The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays! Published: 19-Dec-2012 |
New models hold promise for probiotic claim substantiation
 |
Alwine KardinaalSenior researcher for health and nutrition - Nizo Food ResearchExposing healthy people to modified pathogens in a controlled clinical trial setting could be an exciting new way for industry to overcome the challenges of health claim substantiation, says Nizo Food Research expert. Published: 29-Nov-2012 |
Low barriers of entry have enabled ‘grifters, cobblers, and vermin’ to give industry bad GMP compliance press: BI chief
 |
George PontiakosPresident and CEO - BI NutraceuticalsThe industry’s big names have been complying with GMP regulations for years, but low barriers to entry have made it easy for less serious companies to do business with low GMP compliance, says the chief of BI Nutraceuticals. Published: 21-Nov-2012 |
‘Huge’ opportunities in the emerging cognitive health market: Enzymotec USA CEO
 |
Elzaphan HotamCEO - Enzymotec USAThe cognitive health sector offers huge opportunities for dietary supplements, but it’s still evolving, says the CEO of Enzymotec USA. Published: 21-Nov-2012 |
DuPont on EU probiotic health claim ban: “Mention specific strains”
 |
Michael BondHealth platform leader in Active Nutrition - DuPont Nutrition and HealthGiant of probiotic supply, DuPont, is not afraid to admit its European business has been altered by the rejection of probiotic health claims under the EU nutrition and health claims regulation (NHCR). Published: 21-Nov-2012 |
GMP compliance levels are ‘all over the place’: Alkemists CEO
 |
Elan SudbergCEO - Alkemists LaboratoriesCurrent compliance levels to good manufacturing practice (cGMP) are ‘all over the place’, but ‘for the most part there is an increase in compliance’, says the CEO of Alkemists Laboratories. Published: 20-Nov-2012 |
Demographics will continue to drive cardiovascular category growth: ENI President
 |
Cal BewickePresident - Ethical Naturals Inc.The cardiovascular health segment is here to stay, with the surge in product demand by baby boomers ensuring that growth will continue, says Cal Bewicke, president of Ethical Naturals Inc. Published: 20-Nov-2012 |
'You can feel the difference in half an hour...' PLT on why Zembrin could be a blockbuster
 |
One of the most interesting new product launches at Supply Side West last week was stress-buster Zembrin, the first patented, standardized and clinically studied extract of Sceletium tortuosum, a succulent plant known by the San people of South Africa as ‘Kanna’. Published: 20-Nov-2012 |
Global population demands, ‘confusing’ media coverage and the 100 year old vitamin
 |
Deshanie Rai, PhDSenior Scientific Leader, Human Nutrition & Health - DSM Nutritional ProductsIt’s 100 years since Casimir Funk came up with the term ‘vitamin’, but with an ever-increasing global population and negative reports in the media of their ‘ineffectiveness’ for select health conditions, what does the future hold for the humble vitamin? Published: 19-Nov-2012 |
Dietary supplement industry needs ‘cultural shift’ to deal with GMPs
 |
Jason SapsinSupplement manufacturers – particularly smaller companies – need a ‘cultural shift’ to cope with the demands of good manufacturing practices (GMPs), says a former associate chief counsel with FDA. Published: 19-Nov-2012 |
Arla says UHT-friendly whey can tackle elderly malnutrition
 |
Vivian Kjaer JensenBusiness development manager - Arla Food IngredientsAbout 60% of elderly hospital patients in the UK are malnourished according to recent data from the British Dietetic Association, a problem companies like Danish firm Arla Food Ingredients are trying to tackle with a new whey form. Published: 19-Nov-2012 |
How to show a clinical trial benefit in healthy populations
 |
Jay Udani, MDFounder & CEO - Medicus ResearchBy applying physiological stressors like partial sleep deprivation, it is possible to test the effects of dietary supplements in healthy populations and stay compliant with DSHEA, says Dr Jay Udani, CEO of Medicus Research. Published: 16-Nov-2012 |
Roquette seeks sports blends for pea protein
 |
Aurélie Mauray-Soulier, PhDMarket development manager - RoquetteRoquette is intensifying its research efforts into the protein potential of various plant forms, and used HIE to launch a pea form targeting sports nutrition products. Published: 16-Nov-2012 |
Dry labbing practices ‘mushrooming’ and ‘metamorphosing’: Chromadex CEO
 |
Frank JakschCEO - ChromadexThe practice of dry labbing in the industry is continuing, and the practice is becoming more sophisticated, increasing the need for continued vigilance, says Frank Jaksch, CEO of Chromadex. Published: 16-Nov-2012 |
Functional foodstuffs: The challenge of omega-3 in finished products
 |
Dr Rob WinwoodManager Scientific Communications - DSM Nutritional ProductsThe challenge of getting beneficial omega-3 fatty acids into finished products is a big one for the food ingredients and manufacturing industry. But how can suppliers and manufacturers work to get these ingredients into a wider range of products? Published: 15-Nov-2012 |
Customized nutrition driving growth in healthcare practitioner channel
 |
Jeff HiltonChief Marketing Officer, Co-founder - Integrated Marketing Group (IMG)Consumer demand for personalized nutrition, and the response of healthcare practitioners to the potential for more holistic approaches to patient care and potential additional revenue streams are driving growth in this market channel, says a leading marketing expert. Published: 15-Nov-2012 |
Regulatory momentum to continue for dietary supplements industry: CRN’s Mister
 |
Steve MisterPresident and CEO - Council for Responsible Nutrition (CRN)The results of the recent elections mean that it’s business as usual for the dietary supplements industry, and the defeat of Prop 37 in California is not the end of the genetically engineered food issue, says Steve Mister, President and CEO of CRN. Published: 15-Nov-2012 |
Sourcing non-GMO: Prop 37 supporters have lost the battle, but may ultimately win the war, predicts The Scoular Company
 |
Despite the ‘NO’ vote on Prop 37, the momentum behind sourcing non-GMO ingredients remains as strong as ever, with non-GMO Project verified sales up 66% and a new class action lawsuit against a major food brand over ‘all-natural’ claims on products containing genetically engineered ingredients being filed almost every week. Published: 15-Nov-2012 |
'Our probiotic science will lead to an EFSA health claims approval': DuPont VP of marketing
 |
Scott BushVP Marketing - Nutrition and Health - DuPontRecent studies using DuPont’s HOWARU strain combination, combined with a better understanding of ‘the rules of the game’, will lead to positive health claims in Europe, DuPont’s Scott Bush has confidently predicted. Published: 14-Nov-2012 |
Is finished product testing the next big wave in GMP warning letters?
 |
Aaron SecristQuality & Regulatory Manager - NOW FoodsOnce GMP inspectors from the FDA move beyond the first tier of GMP compliance, the next big wave of warning letters from the agency could be on the issue of finished product testing, says a leading quality and regulatory expert. Published: 14-Nov-2012 |
Is it too risky to market foods containing GMOs as 'all-natural'?
 |
Consumers, market researchers tell us, want foods that are ‘wholesome’, ‘authentic’, and above all ‘natural’, although few of them can articulate what this means. And they are not alone. Regulators have not had much of a stab at defining ‘natural’ either, says Justin Prochnow, an attorney in the Denver office of law firm Greenberg Traurig. Published: 13-Nov-2012 |
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Probiotics: The Path to Better Digestive Health through Quality Clinical Trials
DuPont Nutrition & Health
DuPont Nutrition & Health
